New Global Clinical Trial Tracker for COVID-19 Research
A great resource for tracking the evolution of new clinical trials related to COVID-19. Drill down by intervention type, trial status, and more.
A great resource for tracking the evolution of new clinical trials related to COVID-19. Drill down by intervention type, trial status, and more.
Here’s a review of the latest peer-reviewed and pre-print publications in regards to natural compounds that are showing promising anti-coronavirus activity.
Recently, we discussed the role of zinc in optimizing hydroxychloroquine (HCQ) antiviral benefit. We’ve also been talking about profound potassium (K+) deficiency (hypokalemia) apparently being caused by CoV-2 hijacking of ACE2 receptors.
Join Dr Kara Fitzgerald and Dr Brent Dorval PhD, KBMO Diagnostic’s Chief Scientific Officer, to learn about KBMO’s new COVID-19 Antibody Test. Dr. Dorval previously served as an advisor on the WHO Vaccines and Diagnostics Committee.
A new Harvard-led analysis finds that COVID-19 patients that live in areas with higher air pollution, such as New York City, have experienced a higher death-rate from the infection than those who lived in areas with cleaner air.
In my recent podcast with Dr. John Chen, PharmD, PhD, Dr. Chen pointed us in the direction of this invaluable Handbook put together from the experience of staff at the First Affiliated Hospital, Zhejiang University School of Medicine. Even though our understanding of Sars-CoV-2 continues to evolve, this is still a useful starting point for…
Excellent resources from the Institute for Functional Medicine (IFM), regularly updated, including foundational and straightforward strategies to support sleep and stress, ways to boost immunity, and virus-specific nutraceutical and botanical agents. From the IFM: “IFM is creating a series of position papers for practitioners on how to help their patients prevent and treat infection and…
Ketones (spefically beta-hydroxybutyrate) have shown to inhibit NLRP3 inflammasome activation, which is a key pathological mechanism in COVID-19.
In a study of 175 COVID-positive patients in collaboration with Wenzhou Hospital in China, nearly all were identified as having hypokalemia (low serum potassium), likely due to the mechanisms of COVID-19 on ACE2 receptors and the renin-angiotensin system.
There has been quite a bit of kerfuffle about the workhorse nutrient vitamin D. We are getting pinged daily on whether it should be used or avoided in the COVID19 pandemic. I believe this question was fueled by a recent write-up mentioning an in vitro study showing that D can up-regulate certain cytokines.